Polypeptide-ELISA kit for detecting novel coronavirus S protein unique antibody
A coronavirus and kit technology, applied in the field of peptide-enzyme-linked immunosorbent assay kits, can solve problems such as affecting specificity, and achieve the effects of simple operation, strong specificity, and improved detection accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Example 1: Prediction and determination of the unique dominant linear B cell epitope in the spike protein S on the surface of the novel coronavirus
[0033] According to the characteristics of strong antigenicity, good surface and strong hydrophilicity of the linear B cell epitope, the amino acid sequence of the spike protein S on the surface of the new coronavirus was analyzed using bioinformatics software, and the dominant linear B cell antigen was predicted and determined. Determinant site ( figure 2 ). Use bioinformatics software to compare the amino acid sequences of the surface spike protein S of the new coronavirus SARS-CoV2 with 6 other coronaviruses known to infect humans and cause related diseases, especially the SARS-CoV with the closest homology , to clarify the unique specificity of the above dominant linear B cell epitopes. The peptides were artificially synthesized, and then diluted to 10 micrograms / ml, and coated in a 96-well microtiter plate with an ...
Embodiment 2
[0034] Example 2: Preparation of unique advantage linear B-cell antigen polypeptide on the surface of novel coronavirus spike protein S
[0035] Artificially synthesized four-segment polypeptides (SEQ ID NO.1~SEQ ID NO.4) containing unique dominant linear B cell epitope sites in the surface spike protein S of the novel coronavirus: SQCVNLTTRTQLPPAYTNSFT, HVSGTNGTKRFD, LGVYYHKNNKSWMESEFRVYSS, ALHRSYLTPGDSSSGWTAG, after purification The purity is above 95%.
Embodiment 3
[0036] Example 3: Using the kit to detect the specific antibody of the novel coronavirus surface spike protein S in the sample
[0037] Sample incubation: Take out the microtiter plate in the kit that has been coated with the linear B cell antigen polypeptide with unique specificity and advantages of SARS-CoV2 surface spike protein S. Dilute each sample 100 times with the sample diluent, add to the pre-prepared microplate wells, 100 microliters per well, set up negative control wells, positive control wells and blank wells at the same time, incubate at 37°C for 1 hour, wash with washing solution Plate 3 times.
[0038] Secondary antibody incubation: Dilute the enzyme-labeled antibody 5000 times with sample diluent, add to the wells, 100 microliters per well, incubate at 37°C for 30 minutes and wash the plate 3 times.
[0039] Color development reading: configure OPD color development solution, weigh 20 mg of enzyme substrate C, dissolve in 50 ml of enzyme substrate A, add 20 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com